Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22092116 | 0.91 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL20920211 | 0.89 | ALDH1A1 (0.36) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL20920212 | 0.83 | ALDH1A1 (0.37) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL550030 | 0.76 | MEN1 (0.34) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL20349638 | 0.76 | ALDH1A1 (0.54) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL3797993 | 0.76 | ALDH1A1 (0.54) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL75495 | 0.75 | ALDH1A1 (0.41) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL10179724 | 0.75 | MEN1 (0.33) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL14632832 | 0.74 | ALDH1A1 (0.44) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL10179985 | 0.73 | MEN1 (0.32) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9109072-B2 | Curable composition and uses thereof | SHOWA DENKO K.K. (JP) | 2015-08-18 | — | — | US | disclosed |
| US-20140378571-A1 | CURABLE COMPOSITION AND USES THEREOF | SHOWA DENKO K.K. (JP) | 2014-12-25 | — | — | US | disclosed |
| EP-2813521-A1 | CURABLE COMPOSITION AND APPLICATION THEREFOR | Showa Denko K.K. (JP) | 2014-12-17 | — | — | EP | disclosed |
| US-8110614-B2 | Adamantane derivative, method for producing the same, and resin composition containing adamantane derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20100056663-A1 | ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION CONTAINING ADAMANTANE DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-03-04 | — | — | US | disclosed |
| EP-2090563-A1 | ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION CONTAINING ADAMANTANE DERIVATIVE | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2009-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056663-A1 | ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION CONTAINING ADAMANTANE DERIVATIVE | ARCN1, RTN3, CHRNA3 | ALDH1A1 312/4885TSHR 4644/4885MEN1 3412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.